Marcellusi, A., Bini, C., Fioravanti, L., Ripoli, S. and Morelli, P. 2025. Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy. Global and Regional Health Technology Assessment. 12, 1 (Apr. 2025), 106–117. DOI:https://doi.org/10.33393/grhta.2025.3306.